For: | Feng B, Zhang W, Luo BF, Song GJ, Wang J, Jin Q, Qin H, Wei L. Effect of spleen operation on antiviral treatment in hepatitis C virus-related cirrhotic patients. World J Gastroenterol 2014; 20(41): 15387-15397 [PMID: 25386089 DOI: 10.3748/wjg.v20.i41.15387] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v20/i41/15387.htm |
Number | Citing Articles |
1 |
Ahmed Nagaty, Ekram W. Abd El-Wahab, Tatsuo Kanda. Real-life results of sofosbuvir based therapy in chronic hepatitis C -naïve and -experienced patients in Egypt. PLOS ONE 2017; 12(10): e0184654 doi: 10.1371/journal.pone.0184654
|
2 |
Mohammad I Saleh, Abdullah R Obeidat, Hanan A Anter, Anas A Khanfar. Eltrombopag dose predictors in thrombocytopenic subjects with hepatitis C virus infection. Clinical and Experimental Pharmacology and Physiology 2015; 42(10): 1030 doi: 10.1111/1440-1681.12451
|
3 |
Ahmed Nagaty, Sherine H A Helmy, Ekram W Abd El-Wahab. Sofosbuvir-/Daclatasvir-based therapy for chronic HCV and HCV/hepatitis B virus coinfected patients in Egypt. Transactions of The Royal Society of Tropical Medicine and Hygiene 2020; 114(3): 200 doi: 10.1093/trstmh/trz079
|